Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Oral Cannabidiol and Tetrahydrocannabinol for Essential Tremor
This double-blind, randomized, placebo-controlled efficacy and tolerability pilot trial did not detect any signals of efficacy of oral cannabidiol and tetrahydrocannabinol in reducing essential tremor amplitude using either digital outcome measures or clinical rating scales. The oral cannabinoids were well-tolerated by most (five out of seven) participants.
Authors
- Brenton A. Wright (ORCID: https://orcid.org/0000-0002-0825-6524)
- F. Xavier Castellanos (ORCID: https://orcid.org/0000-0001-9192-9437)
- Fatta B. Nahab (ORCID: https://orcid.org/0000-0002-2452-4939)
- Jeremiah D. Momper (ORCID: https://orcid.org/0000-0002-3154-6685)
- Katherine Longardner (ORCID: https://orcid.org/0000-0001-5479-2590)
- Rhea Gandhi (ORCID: https://orcid.org/0009-0003-9922-787X)
- Bin Tang (ORCID: https://orcid.org/0009-0005-9317-9226)
- Shen Qian (ORCID: https://orcid.org/0000-0002-3868-5303)
Institutions
- University of California San Diego (US)
- New York University (US)
Publication Details
- Journal
- Tremor and Other Hyperkinetic Movements
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5334/tohm.1005
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00